Skip to main content
OpenTrials
Completed

NCT Number: NCT01782092

Activator and Type II Diabetics

The purpose of this study (15-subject prospective case series) is to examine the effects of the Activator Methods technique on decreasing A1c levels in patients with type II Diabetes Mellitus (aka adult-onset diabetes).

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Life University

Marietta, Georgia, 30060, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects will be eligible to participate in the study if they are between the ages of 30-60 and are clinically diagnosed with Type II diabetes by their primary care providers or endocrinologists (diagnosis usually based on FPG > 126 mg/dL on two occasions).
  • Participants must have been diagnosed for at least one year and currently be under medical supervision for the disease.
  • They must also have an A1c measurement above 7%, which indicates less than optimal management of the disease.

Exclusion criteria

  • The study will exclude pregnant women;
  • those with co-morbidities affecting life expectancy (e.g. malignancy, CVD); uncontrolled hypertension (> 150/100 mmHg);
  • serious trauma (e.g. MVA) within the previous 12 months;
  • diagnosed bleeding/clotting disorders; those currently under chiropractic care or having contraindications to Activator care (e.g. vertebral fracture, infection, active inflammatory arthritis, severe osteoporosis).

The presence of these exclusions will be determined during the history and exam procedures. All female subjects will be asked to take precautions during their participation in the study to avoid becoming pregnant.

Treatment and study plan

Chiropractic Adjustment

Other

Chiropractic adjustments will be administered using Activator Methods Basic protocol

Primary outcomes

  1. Lowered A1C Levels

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Life University

Other

Registry information

Official study title

Effect of Activator Methods Technique on Lowering A1c Levels in Type II Diabetics

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Feb 1, 2013
Registry last updated
Apr 20, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.